CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
NeoMatriX Wound MatriX Collagen Dressingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03522675
NCT03522675N/ACompleted

Skin Prick Test in Healthy Volunteers of Any Sex, to Investigate the Potential Allergy to NeoMatriXTM Wound Matrix

NeXtGen Biologics, Inc.·interventional·Posted May 11, 2018·Updated May 31, 2019

In Brief

A clinical study evaluating NeoMatriX Wound MatriX Collagen Dressing for Allergy Skin and 2 related conditions. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The objective of this study is to investigate the potential of NeoMatriXTM Wound Matrix to cause an allergic response to healthy volunteers using a skin prick test.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 11, 2018
Enrollment StartApr 11, 2018
Primary CompletionApr 26, 2018
Study CompletionApr 28, 2018
TodayJul 2, 2026
Enrollment to primary: 15 daysPosted 8.1 years ago

Interventions

NeoMatriX Wound MatriX Collagen Dressingdevice

Collagen wound dressing